26 results found
दवा प्रतिरोधी संक्रमणों के लिए भारत ने नैफिथ्रोमाइसिन न�
HIV/AIDS विरुद्धचा लढा सुरू ठेवण्यासाठी भारताने अवलंबलेली धो
It is essential to focus on tailored policies and prevention strategies that India must adopt to continue its fight against HIV/AIDS.
To address the issue of poor healthcare infrastructure, the states need to prioritise this sector by diverting funds, creating more capacity in existi
Despite facing several challenges, Delhi’s mohalla clinics have been instrumental in providing healthcare services to the poor and underserved.
Would the newly appointed Prime Minister, Ranil Wickremesinghe, be able to steer Sri Lanka away from the economic and political crisis?
The world needs the vaccine today — not tomorrow — to stop the disease and end the pandemic. We need to embrace the access to medicine movement �
दुनिया भर में फैली कोविड-19 की महामारी के चलते 96 मिलियन लोग �
The difference between conventional and alternative medicine must eventually be removed so that the medicines that work are available to all practitio
Pakistan’s knee-jerk decision to suspend all trade relations with India could have only created a barrier of access to medicines for the Pakistani p
In a country like India, where systems to study and document long term effects of poor quality medicines are sparse at best, addressing structural iss
The knowledge base, strength and capabilities of the Indian pharma have not been appreciated and image of Indian pharma industry is constantly being m
There is a groundswell in Africa in support of local pharmaceutical production. Africa's dependency on the rest of the world for medicines may not las
बेशक चीन के साथ मौजूदा संबंधों में आत्मसंतुष्टि की कोई �
There is indeed no room for complacency while dealing with China, but as a big market for Chinese goods, that should not prevent India from using Chin
Africa faces various challenges in ensuring equitable access to life-saving drugs. Drug prices in the continent are largely unregulated, making locally produced drugs more expensive than the imported ones. The African countries thus rely heavily on imports to meet their pharmaceutical needs. Further, the medicine delivery systems in the countries are encumbered by the poor implementation of regulatory policies, if they are in place at all. East A
Rolling out a half-baked populist agenda is likely to backfire and be detrimental to the public health agenda.
Expanding investments, collaboration between departments, fostering public-private partnerships, and engaging the community are crucial for health care in India
A no-deal Brexit would be economically disastrous for the UK and might even lead to shortage of medicines and food in the short- to medium-term. However that is not Boris Johnson’s concern at the moment.
The global economic slowdown presents an opportunity for the Indian industry to work on low cost medicines
Questions about the utility of globalisation are not new. Could the COVID-19 outbreak be the final nail on the coffin for an idea that drove the world economy in the past three decades? In theory, countries would produce what they specialised in, leaving it to the market to ensure everyone got a better price for it. As 2020 began, the pandemic spread from one province of China and soon disrupted production across the world. Countries banned the
The expansion of access to affordable drugs will play a central role in addressing present and future global health challenges. Given the vast social implications of increased access to medicines, the Indian patent system has historically maintained a pro-public health stand. However, the international political community is increasingly advocating for stricter patent regimes and India can no longer continue to ignore the pressure exerted by deve
